| 产品名称： | Purpureocillium lilacinum (Thom) Luangsa-ard et al. |
|---|---|
| 商品货号： | TS205976 |
| Deposited As： | Penicillium lilacinum Thom |
| Strain Designations： | NRRL 895 8, ATCC 1123, CBS 284.36, DSM 846, IMI 27830, QM 7592 |
| Application： | produces carbomycin derivatives magnamycin derivatives produces dextranase produces leucomycin derivatives produces niddamycin derivatives produces paecilotoxin produces steroids |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Storage Conditions： | Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section |
| Type Strain： | yes |
| Preceptrol®： | no |
| Medium： | ATCC® Medium 312: Czapeks agar ATCC® Medium 325: Malt extract agar (Blakeslees formula) ATCC® Medium 336: Potato dextrose agar (PDA) |
| Growth Conditions： | Temperature: 24°C to 26°C Atmosphere: Typical aerobic |
| Sequenced Data： |
18S ribosomal RNA gene, partial sequence; internal transcribed spacer 1, 5.8S ribosomal RNA gene, and internal transcribed spacer 2, complete sequence; and 28/26S ribosomal RNA gene, partial sequence AGGGATCATTACCGAGTTATACAACTCCCAAACCCACTGTGAACCTTACCTCAGTTGCCTCGGCGGGAACGCCCCGGCCGCCTGCCCCCGCGCCGGCGCCGGACCCAGGCGCCCGCCGCAGGGACCCCAAACTCTCTTGCATTACGCCCAGCGGGCGGAATTTCTTCTCTGAGTTGCACAAGCAAAAACAAATGAATCAAAACTTTCAACAACGGATCTCTTGGTTCTGGCATCGATGAAGAACGCAGCGAAATGCGATAAGTAATGTGAATTGCAGAATTCAGTGAATCATCGAATCTTTGAACGCACATTGCGCCCGCCAGCATTCTGGCGGGCATGCCTGTTCGAGCGTCATTTCAACCCTCGAGCCCCCCCGGGGGCCTCGGTGTTGGGGGACGGCACACCAGCCGCCCCCGAAATGCAGTGGCGACCCCGCCGCAGCCTCCCCTGCGTAGTAGCACACACCTCGCACCGGAGCGCGGAGGCGGTCACGCCGTAAAACGCCCAACTTTCTTAGAGTTGACCTCGGATCAGGTAGGAATACCCGCTGAACTTAAG D1D2 region of the 28/26S ribosomal RNA gene CATATCAATAAGCGGAGGAAAAGAAACCAACAGGGATTGCCCCAGTAACGGCGAGTGAAGCGGCAACAGCTCAAATTTGAAATCTGGCCCCCAGGGCCCGAGTTGTAATTTGCAGAGGATGCTTTTGGCGCGGTGCCTTCCGAGTTCCCTGGAACGGGACGCCATAGAGGGTGAGAGCCCCGTCTGGTCGGACGCCTAGCCTGTGTAAAGCTCCTTCGACGAGTCGAGTAGTTTGGGAATGCTGCTCTAAATGGGAGGTATATGTCTTCTAAAGCTAAATACCGGCCAGAGACCGATAGCGCACAAGTAGAGTGATCGAAAGATGAAAAGCACTTTGAAAAGAGGGTTAAATAGTACGTGAAATTGTTGAAAGGGAAGCGCTTGTGACCAGACTTGGGCCCGGTGGATCATCCAGCGTTCTCGCTGGTGCACTCCGCCGGGTTCAGGCCAGCATCAGTTCGCCGCGGGGGAAAAAGGCTTCGGGAACGTGGCTCCTACGGGAGTGTTATAGCCCGTTGCATAATACCCTGGGGCGGACTGAGGTTCGCGCTCCGCAAGGATGCTGGCGTAATGGTCATCAGCGA |
| Name of Depositor： | NRRL |
| Chain of Custody： | ATCC <-- NRRL <-- C. Thom 8 <-- G. Atkinson and C. Edgarton |
| Isolation： | Soil, Ithaca, NY |
| References： | Theriault RJ. Mycarosyl macrolide antibiotics. US Patent 3,784,447 dated Jan 8 1974 Thom C. Cultural studies of species of Penicillium. U.S. Dep. Agric. Bur. Anim. Ind. 118: 1-109, 1910. Walker GJ, Pulkownik A. Action of alpha-1,6,-glucan glucohydrolase on oligosaccharides derived from dextran. Carbohydr. Res. 36: 53-66, 1974. PubMed: 4369744 Carlstrom K. Side chain degradation and 20-(alpha+beta)-reduction of progesterone by cell free preparations of Penicillium lilacinum NRRL 895. Acta Chem. Scand. Ser. B Org. Chem. Biochem. 26: 1718-1720, 1972. Carlstrom K. Transformations of steroids by cell free preparations of Penicillium lilacinum NRRL 895. IV. Enzyme catalyzed acyl transfer. Acta Chem. Scand. 28: 23-28, 1974. Lee JM, Fox PF. Purification and characterization of Paecilomyces lilacinus dextranase. Enzyme Microb. Technol. 7: 573-577, 1985. Mikami Y, et al. Paecilotoxin production in clinical or terrestrial isolates of Paecilomyces lilacinus strains. Mycopathologia 108: 195-199, 1989. PubMed: 2615806 Luangsa-Ard J, et al. Purpureocillium, a new genus for the medically important Paecilomyces lilacinus. FEMS Microbiol Lett 321: 141-149, 2011. PubMed: 21631575 |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Purpureocillium lilacinum (Thom) Luangsa-ard et al. |
|---|---|
| 商品货号： | TS205976 |
| Deposited As： | Penicillium lilacinum Thom |
| Strain Designations： | NRRL 895 8, ATCC 1123, CBS 284.36, DSM 846, IMI 27830, QM 7592 |
| Application： | produces carbomycin derivatives magnamycin derivatives produces dextranase produces leucomycin derivatives produces niddamycin derivatives produces paecilotoxin produces steroids |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Storage Conditions： | Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section |
| Type Strain： | yes |
| Preceptrol®： | no |
| Medium： | ATCC® Medium 312: Czapeks agar ATCC® Medium 325: Malt extract agar (Blakeslees formula) ATCC® Medium 336: Potato dextrose agar (PDA) |
| Growth Conditions： | Temperature: 24°C to 26°C Atmosphere: Typical aerobic |
| Sequenced Data： |
18S ribosomal RNA gene, partial sequence; internal transcribed spacer 1, 5.8S ribosomal RNA gene, and internal transcribed spacer 2, complete sequence; and 28/26S ribosomal RNA gene, partial sequence AGGGATCATTACCGAGTTATACAACTCCCAAACCCACTGTGAACCTTACCTCAGTTGCCTCGGCGGGAACGCCCCGGCCGCCTGCCCCCGCGCCGGCGCCGGACCCAGGCGCCCGCCGCAGGGACCCCAAACTCTCTTGCATTACGCCCAGCGGGCGGAATTTCTTCTCTGAGTTGCACAAGCAAAAACAAATGAATCAAAACTTTCAACAACGGATCTCTTGGTTCTGGCATCGATGAAGAACGCAGCGAAATGCGATAAGTAATGTGAATTGCAGAATTCAGTGAATCATCGAATCTTTGAACGCACATTGCGCCCGCCAGCATTCTGGCGGGCATGCCTGTTCGAGCGTCATTTCAACCCTCGAGCCCCCCCGGGGGCCTCGGTGTTGGGGGACGGCACACCAGCCGCCCCCGAAATGCAGTGGCGACCCCGCCGCAGCCTCCCCTGCGTAGTAGCACACACCTCGCACCGGAGCGCGGAGGCGGTCACGCCGTAAAACGCCCAACTTTCTTAGAGTTGACCTCGGATCAGGTAGGAATACCCGCTGAACTTAAG D1D2 region of the 28/26S ribosomal RNA gene CATATCAATAAGCGGAGGAAAAGAAACCAACAGGGATTGCCCCAGTAACGGCGAGTGAAGCGGCAACAGCTCAAATTTGAAATCTGGCCCCCAGGGCCCGAGTTGTAATTTGCAGAGGATGCTTTTGGCGCGGTGCCTTCCGAGTTCCCTGGAACGGGACGCCATAGAGGGTGAGAGCCCCGTCTGGTCGGACGCCTAGCCTGTGTAAAGCTCCTTCGACGAGTCGAGTAGTTTGGGAATGCTGCTCTAAATGGGAGGTATATGTCTTCTAAAGCTAAATACCGGCCAGAGACCGATAGCGCACAAGTAGAGTGATCGAAAGATGAAAAGCACTTTGAAAAGAGGGTTAAATAGTACGTGAAATTGTTGAAAGGGAAGCGCTTGTGACCAGACTTGGGCCCGGTGGATCATCCAGCGTTCTCGCTGGTGCACTCCGCCGGGTTCAGGCCAGCATCAGTTCGCCGCGGGGGAAAAAGGCTTCGGGAACGTGGCTCCTACGGGAGTGTTATAGCCCGTTGCATAATACCCTGGGGCGGACTGAGGTTCGCGCTCCGCAAGGATGCTGGCGTAATGGTCATCAGCGA |
| Name of Depositor： | NRRL |
| Chain of Custody： | ATCC <-- NRRL <-- C. Thom 8 <-- G. Atkinson and C. Edgarton |
| Isolation： | Soil, Ithaca, NY |
| References： | Theriault RJ. Mycarosyl macrolide antibiotics. US Patent 3,784,447 dated Jan 8 1974 Thom C. Cultural studies of species of Penicillium. U.S. Dep. Agric. Bur. Anim. Ind. 118: 1-109, 1910. Walker GJ, Pulkownik A. Action of alpha-1,6,-glucan glucohydrolase on oligosaccharides derived from dextran. Carbohydr. Res. 36: 53-66, 1974. PubMed: 4369744 Carlstrom K. Side chain degradation and 20-(alpha+beta)-reduction of progesterone by cell free preparations of Penicillium lilacinum NRRL 895. Acta Chem. Scand. Ser. B Org. Chem. Biochem. 26: 1718-1720, 1972. Carlstrom K. Transformations of steroids by cell free preparations of Penicillium lilacinum NRRL 895. IV. Enzyme catalyzed acyl transfer. Acta Chem. Scand. 28: 23-28, 1974. Lee JM, Fox PF. Purification and characterization of Paecilomyces lilacinus dextranase. Enzyme Microb. Technol. 7: 573-577, 1985. Mikami Y, et al. Paecilotoxin production in clinical or terrestrial isolates of Paecilomyces lilacinus strains. Mycopathologia 108: 195-199, 1989. PubMed: 2615806 Luangsa-Ard J, et al. Purpureocillium, a new genus for the medically important Paecilomyces lilacinus. FEMS Microbiol Lett 321: 141-149, 2011. PubMed: 21631575 |
